The University of Chicago Header Logo

Search Result Details

Back to Search Results
This page shows the details of why an item matched the keywords from your search.
Search Results
Hanauer, Stephen
One or more keywords matched the following items that are connected to Hanauer, Stephen
Item TypeName
Concept Severity of Illness Index
Academic Article Mesalamine capsules for the treatment of active Crohn's disease: results of a 16-week trial. Pentasa Crohn's Disease Study Group.
Academic Article A comparison of the quality of life in patients with severe ulcerative colitis after total colectomy versus medical treatment with intravenous cyclosporin.
Academic Article Medical therapy for inflammatory bowel disease.
Academic Article Recombinant human interleukin 10 in the treatment of patients with mild to moderately active Crohn's disease. The Interleukin 10 Inflammatory Bowel Disease Cooperative Study Group.
Academic Article Linkage heterogeneity for the IBD1 locus in Crohn's disease pedigrees by disease onset and severity.
Academic Article Efficacy and safety of retreatment with anti-tumor necrosis factor antibody (infliximab) to maintain remission in Crohn's disease.
Academic Article Medical treatment of Crohn's disease.
Academic Article Smoking and inflammatory bowel disease.
Academic Article Safety and efficacy of recombinant human interleukin 10 in chronic active Crohn's disease. Crohn's Disease IL-10 Cooperative Study Group.
Academic Article A review of activity indices and efficacy endpoints for clinical trials of medical therapy in adults with Crohn's disease.
Academic Article Fecal lactoferrin is a sensitive and specific marker in identifying intestinal inflammation.
Academic Article Incidence and importance of antibody responses to infliximab after maintenance or episodic treatment in Crohn's disease.
Academic Article The state of the art in the management of inflammatory bowel disease.
Academic Article Unemployment and disability in patients with moderately to severely active Crohn's disease.
Academic Article Crohn's is not a 6-week disease: lifelong management of mild to moderate Crohn's disease.
Academic Article Emerging biologic therapies in inflammatory bowel disease.
Academic Article Rifaximin for the treatment of active pouchitis: a randomized, double-blind, placebo-controlled pilot study.
Academic Article Defining the optimal response criteria for the Crohn's disease activity index for induction studies in patients with mildly to moderately active Crohn's disease.
Academic Article Maintaining remissions across the lifespan: a roundtable discussion with Crohn's disease experts.
Academic Article Management of Crohn's disease in adults.
Academic Article A randomized, double-blind, sham-controlled study of granulocyte/monocyte apheresis for active ulcerative colitis.
Academic Article Devolving therapeutic pyramids.
Academic Article Scheduled maintenance treatment with infliximab is superior to episodic treatment for the healing of mucosal ulceration associated with Crohn's disease.
Academic Article Continuous therapy with certolizumab pegol maintains remission of patients with Crohn's disease for up to 18 months.
Academic Article Adalimumab for maintenance of clinical response and remission in patients with Crohn's disease: the CHARM trial.
Academic Article Rosiglitazone for active ulcerative colitis: a randomized placebo-controlled trial.
Academic Article A phase I study of visilizumab, a humanized anti-CD3 monoclonal antibody, in severe steroid-refractory ulcerative colitis.
Academic Article Budesonide as maintenance treatment in Crohn's disease: a placebo-controlled trial.
Academic Article Colectomy rate comparison after treatment of ulcerative colitis with placebo or infliximab.
Academic Article Update on the management of ulcerative colitis.
Academic Article Early mucosal healing with infliximab is associated with improved long-term clinical outcomes in ulcerative colitis.
Academic Article Extracorporeal photopheresis for the treatment of refractory Crohn's disease: results of an open-label pilot study.
Academic Article Developing an instrument to assess the endoscopic severity of ulcerative colitis: the Ulcerative Colitis Endoscopic Index of Severity (UCEIS).
Academic Article Delayed-release oral mesalamine 4.8 g/day (800-mg tablet) is effective for patients with moderately active ulcerative colitis.
Academic Article Pilot feasibility studies of leukocytapheresis with the Adacolumn Apheresis System in patients with active ulcerative colitis or Crohn disease.
Academic Article A review of activity indices and efficacy end points for clinical trials of medical therapy in adults with ulcerative colitis.
Academic Article Ustekinumab induction and maintenance therapy in refractory Crohn's disease.
Academic Article Delayed-release oral mesalamine 4.8 g/day (800 mg tablets) compared to 2.4 g/day (400 mg tablets) for the treatment of mildly to moderately active ulcerative colitis: The ASCEND I trial.
Academic Article Randomised clinical trial: certolizumab pegol for fistulas in Crohn's disease - subgroup results from a placebo-controlled study.
Academic Article Adalimumab for induction of clinical remission in moderately to severely active ulcerative colitis: results of a randomised controlled trial.
Academic Article Efficacy of biological therapies in inflammatory bowel disease: systematic review and meta-analysis.
Academic Article A randomized, double-blind, placebo-controlled trial of CDP571, a humanized monoclonal antibody to tumour necrosis factor-alpha, in patients with corticosteroid-dependent Crohn's disease.
Academic Article Evaluation of a daily practice composite score for the assessment of Crohn's disease: the treatment impact of certolizumab pegol.
Academic Article Long-term infliximab maintenance therapy for ulcerative colitis: the ACT-1 and -2 extension studies.
Academic Article Low-dose smoking resumption in ex-smokers with refractory ulcerative colitis.
Academic Article Reliability and initial validation of the ulcerative colitis endoscopic index of severity.
Academic Article Inflammation is an independent risk factor for colonic neoplasia in patients with ulcerative colitis: a case-control study.
Academic Article A randomised, double-blind, sham-controlled study of granulocyte/monocyte apheresis for moderate to severe Crohn's disease.
Academic Article The Impact of Clinical Information on the Assessment of Endoscopic Activity: Characteristics of the Ulcerative Colitis Endoscopic Index Of Severity [UCEIS].
Academic Article Defining Disease Severity in Inflammatory Bowel Diseases: Current and Future Directions.
Academic Article Development of an index to define overall disease severity in IBD.
Academic Article Histologic Normalization Occurs in Ulcerative Colitis and Is Associated With Improved Clinical Outcomes.
Academic Article Optimizing pharmacologic management of inflammatory bowel disease.
Academic Article Clinical Response and Complications are not Associated with Drug Levels in Patients with Severe Ulcerative Colitis on IV Cyclosporine Induction Therapy.
Academic Article Pharmacokinetics and Exposure Response Relationships of Ustekinumab in Patients With Crohn's Disease.
Academic Article Initial Assessment of Post-traumatic Stress in a US Cohort of Inflammatory Bowel Disease Patients.
Academic Article Time to Symptom Resolution in Ulcerative Colitis With Multimatrix Mesalazine Treatment: A Pooled Analysis.
Academic Article Segmental Histological Normalisation Occurs in Ulcerative Colitis but Does Not Improve Clinical Outcomes.
Academic Article Safety and efficacy of BI 695501 versus adalimumab reference product in patients with advanced Crohn's disease (VOLTAIRE-CD): a multicentre, randomised, double-blind, phase 3 trial.
Academic Article Etrolizumab for maintenance therapy in patients with moderately to severely active ulcerative colitis (LAUREL): a randomised, placebo-controlled, double-blind, phase 3 study.
Search Criteria
  • Severity of Illness Index